Jump to content

Myrophine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Chris the speller (talk | contribs) at 14:06, 14 October 2016 (top: replaced: longer lasting → longer-lasting, typo(s) fixed: Consequently → Consequently, using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Myrophine
Clinical data
Other namesMyristylbenzylmorphine
ATC code
  • none
Legal status
Legal status
Identifiers
  • 7,8-didehydro-4,5α-epoxy-17-methyl-3-(phenylmethoxy)-morphinan-6-ol tetradecanoate
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC38H51NO4
Molar mass585.82 g/mol g·mol−1
3D model (JSmol)
  • CCCCCCCCCCCCCC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OCC6=CC=CC=C6)CCN3C
  • InChI=1S/C38H51NO4/c1-3-4-5-6-7-8-9-10-11-12-16-19-34(40)42-33-23-21-30-31-26-29-20-22-32(41-27-28-17-14-13-15-18-28)36-35(29)38(30,37(33)43-36)24-25-39(31)2/h13-15,17-18,20-23,30-31,33,37H,3-12,16,19,24-27H2,1-2H3/t30-,31+,33-,37-,38-/m0/s1
  • Key:GODGZZGKTZQSAL-VXFFQEMOSA-N
  (verify)

Myrophine (Myristylbenzylmorphine) is an opiate analogue that was developed in 1952. It is a derivative of morphine.

Myrophine is substituted with a 3-benzyl group and a 6-myristyl chain. It is metabolised to form benzylmorphine and then further to morphine, and so is a long-acting prodrug for morphine, but with a slow onset of effects. It is weaker than morphine as an analgesic but longer-lasting in effects, and was thought to have more local anesthetic effect than morphine, though with a somewhat greater tendency to cause histamine reactions like itching and rash. In addiction studies conducted in human subjects in the 1950s, myrophine did not substitute for morphine in withdrawal, did not produce notable morphine-like effects, and did not produce addiction or dependence regardless of dose or how it was administered. Consequently, it was thought to be useful in treating pain in addicts who were being detoxified from other opioid drugs.[1]

It is a Schedule I drug in the USA, considered to have high potential for abuse and no medical applications, and is controlled under international drug conventions. Myrophine is almost invariably used as the hydrochloride (free base conversion ratio 0.94) and has a DEA Administrative Controlled Substance Control Number of 9308. Myrophine is a Class A controlled substance in the UK,[2] and is on the UN's Yellow list.

References

  1. ^ Eddy NB, Halbach H, Braenden OJ. Synthetic Substances with Morphine-Like Effect. Bulletin of the World Health Organisation 1957,17:694-696.
  2. ^ "Part I Class A Drugs - IsomerDesign". 2012-03-03. Retrieved 2012-03-24.